Postoperative medicine for chondroblastoma

Abstract

The invention discloses a postoperative medicine for chondroblastoma, which aims to solve the problem high recurrence rate of chondroblastoma. The invention is characterized by comprising the following active pharmaceutical ingredients in parts by weight: lychee seed, poncirus bark, Trachelospermum jasminoides, retinervus luffae fructus, murraya jasminorage, princesplume ladysthumb fruit, balloonflower, kudzu root, Paris polyphylla, Twin-sorus Fern, red fruit figtree leaf and charred rice sprout. The clinical experiment proves that the postoperative medicine has the characteristics of good auxiliary curative effect on chondroblastoma and high safety, and is worthy of clinical application and popularization.

Description

technical field [0001] The invention relates to the field of medicine for orthopedics, in particular to a medicine for postoperative chondroblastoma. Background technique [0002] Chondroblastoma (benign chondroblastoma) is a common cartilaginous neoplasm of the epiphysis that develops before termination of endochondral bone formation. Most of them occur in the center of the epiphysis of long bones, especially in the major trochanters and the greater tuberosity of the epiphysis other than the end epiphysis. Long bones such as the upper and lower ends of the femur and the upper and lower ends of the tibia are the predilection sites, and the incidence near the knee joint accounts for almost half of the total number of tumors. Codman's tumor was also called Codman's tumor because it was first reported by Codman on the upper end of the humerus. [0003] The treatment of benign chondroblastoma is based on bone grafting after complete curettage of tumor tissue. The postoperati...

AI Technical Summary

Problems solved by technology

However, there is still no drug to prevent tumor recurrence